278 related articles for article (PubMed ID: 10493881)
1. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
Lu D; Fütterer K; Korolev S; Zheng X; Tan K; Waksman G; Sadler JE
J Mol Biol; 1999 Sep; 292(2):361-73. PubMed ID: 10493881
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
3. Strategy for improvement of enteropeptidase efficiency in tag removal processes.
Gasparian ME; Bychkov ML; Dolgikh DA; Kirpichnikov MP
Protein Expr Purif; 2011 Oct; 79(2):191-6. PubMed ID: 21515380
[TBL] [Abstract][Full Text] [Related]
4. [Hydrolysis by enteropeptidase of nonspecific (model) peptide sequences and possible physiological role of this phenomenon].
Likhareva VV; Mikhaĭlova AG; Rumsh LD
Vopr Med Khim; 2002; 48(6):561-9. PubMed ID: 12698555
[TBL] [Abstract][Full Text] [Related]
5. Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain.
Lu D; Yuan X; Zheng X; Sadler JE
J Biol Chem; 1997 Dec; 272(50):31293-300. PubMed ID: 9395456
[TBL] [Abstract][Full Text] [Related]
6. Dissecting structural basis of the unique substrate selectivity of human enteropeptidase catalytic subunit.
Ostapchenko VG; Gasparian ME; Kosinsky YA; Efremov RG; Dolgikh DA; Kirpichnikov MP
J Biomol Struct Dyn; 2012; 30(1):62-73. PubMed ID: 22571433
[TBL] [Abstract][Full Text] [Related]
7. Engineered recombinant enteropeptidase catalytic subunit: effect of N-terminal modification.
Song HW; Choi SI; Seong BL
Arch Biochem Biophys; 2002 Apr; 400(1):1-6. PubMed ID: 11913964
[TBL] [Abstract][Full Text] [Related]
8. Design and efficient production of bovine enterokinase light chain with higher specificity in E. coli.
Chun H; Joo K; Lee J; Shin HC
Biotechnol Lett; 2011 Jun; 33(6):1227-32. PubMed ID: 21331584
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
10. Evolution of trypsinogen activation peptides.
Chen JM; Kukor Z; Le Maréchal C; Tóth M; Tsakiris L; Raguénès O; Férec C; Sahin-Tóth M
Mol Biol Evol; 2003 Nov; 20(11):1767-77. PubMed ID: 12832630
[TBL] [Abstract][Full Text] [Related]
11. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
[TBL] [Abstract][Full Text] [Related]
12. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
13. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
14. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
15. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
[TBL] [Abstract][Full Text] [Related]
16. Specificity studies on enteropeptidase substrates related to the N-terminus of trypsinogen.
Jenö P; Green JR; Lentze MJ
Biochem J; 1987 Feb; 241(3):721-7. PubMed ID: 3297038
[TBL] [Abstract][Full Text] [Related]
17. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
19. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
